About Mechanisms in Myeloma and
Related Diseases

Mechanisms in Myeloma is an online CME resource, with content developed by an expert, multidisciplinary panel of specialists.

The content on this Website is intended for medical oncologists, hematologists, stem cell transplant physicians, and other interested healthcare professionals who manage and treat myeloma and related diseases in the hematology/oncology and transplant patient settings.

The purpose of this Website is to provide an e-learning resource about the mechanisms in myeloma. Each comprehensive learning module includes:

  • Text, authored by leading experts in the treatment and management of myeloma
  • Slide presentations
  • Clinical case studies
  • Medical animations
  • Physician self-evaluation questionnaires
Click here to view the Learning Objectives for this educational Website.

Content Highlights
Multiple myeloma is a malignant plasma-cell proliferative disorder with an expected 19,920 new cases and 10,690 deaths in the United States in 2008. Myeloma accounts for about 1% of all malignancies and is the second most common hematologic malignancy.
The male-to-female ratio is
1.3 to 1, and the median
age at diagnosis is 70
years of age.

Please register to learn more

Dr Elias J. Anaissie
Dr Bart Barlogie

Editorial Faculty
Dr James R. Berenson
Dr Raymond L. Comenzo
Dr Angela Dispenzieri
Dr Steven P. Treon
Dr Donna M. Weber
About Us | Contact Us | Terms of Use | Privacy Policy | Technical Requirements | Site Map | Help